PACS Group, Inc. (PACS) P/E Ratio History
Historical price-to-earnings valuation from 2024 to 2025
Loading P/E history...
PACS Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, PACS Group, Inc. (PACS) trades at a price-to-earnings ratio of 27.6x, with a stock price of $33.62 and trailing twelve-month earnings per share of $1.22.
The current P/E is 32% above its 5-year average of 20.9x. Over the past five years, PACS's P/E has ranged from a low of 13.2x to a high of 31.5x, placing the current valuation at the 86th percentile of its historical range.
Compared to the Financial Services sector median P/E of 13.1x, PACS trades at a 110% premium to its sector peers. The sector includes 775 companies with P/E ratios ranging from 0.0x to 195.8x.
Relative to the broader market, PACS trades roughly in line with the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PACS DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
PACS P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $10B | 29.8 | 2.16 | +14% | |
| $3B | 22.3 | 0.97 | +17% | |
| $2B | 18.7 | 0.93Best | +23%Best | |
| $2B | 13.9Lowest | - | -29% | |
| $6B | 23.1 | - | -7% | |
| $336B | 27.9 | - | -15% | |
| $30B | 25.1 | - | -1% | |
| $111B | 62.8 | - | -62% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
PACS Historical P/E Data (2024–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $38.39 | $1.22 | 31.5x | +50% |
| FY2025 Q3 | $13.73 | $1.04 | 13.2x | -37% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $12.92 | $0.82 | 15.8x | -25% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $11.24 | $0.44 | 25.7x | +23% |
| FY2024 Q4 | $13.11 | $0.60 | 22.0x | +5% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $39.97 | $1.75 | 22.9x | +9% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $29.50 | $1.90 | 15.6x | -26% |
Average P/E for displayed period: 20.9x
See PACS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PACS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PACS vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonPACS — Frequently Asked Questions
Quick answers to the most common questions about buying PACS stock.
Is PACS stock overvalued or undervalued?
PACS trades at 27.6x P/E, above its 5-year average of 20.9x. The 86th percentile ranking indicates a premium to historical valuation.
How does PACS's valuation compare to peers?
PACS Group, Inc. P/E of 27.6x compares to sector median of 13.1x. The premium reflects expected growth above peers.
What is PACS's PEG ratio?
PACS PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2024-2025.